![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ruetter A. Luger T.A.
Publisher: Adis International
ISSN: 1175-0561
Source: American Journal of Clinical Dermatology, Vol.5, Iss.3, 2004-01, pp. : 153-160
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Gürcan Hakan M. Jeph Sunil Ahmed A. Razzaque
American Journal of Clinical Dermatology, Vol. 11, Iss. 5, 2010-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Management of Immune-Mediated Uveitis
BioDrugs, Vol. 13, Iss. 1, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus: Potential for Immunotherapy
BioDrugs, Vol. 15, Iss. 5, 2001-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Use of Intravenous Immunoglobulin in Multiple Sclerosis
By Achiron A.
BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders
By Larroche C.
BioDrugs, Vol. 16, Iss. 1, 2002-01 ,pp. :